Long term biochemical recurrence free survival after radical prostatectomy for cancer: Comparative analysis according to surgical approach and clinicopathological stage

被引:1
作者
Rizk, J. [1 ]
Ouzzane, A. [1 ]
Flamand, V. [1 ]
Fantoni, J. -C. [1 ]
Puech, P. [2 ]
Leroy, X. [3 ]
Villers, A. [1 ]
机构
[1] Univ Lille Nord De France, CHRU Lille, Serv Urol, F-59000 Lille, France
[2] Univ Lille Nord De France, CHRU Lille, Serv Radiol, F-59000 Lille, France
[3] Univ Lille Nord De France, CHRU Lille, Inst Pathol, F-59000 Lille, France
来源
PROGRES EN UROLOGIE | 2015年 / 25卷 / 03期
关键词
Prostatectomy; Outcome assessment; Prostatic neoplasms; Recurrence; Disease-free survival; CLASSIFICATION; VALIDATION; PREDICTORS; OUTCOMES; MARGINS;
D O I
10.1016/j.purol.2014.12.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. - To assess long term biochemical recurrence free survival after radical prostatectomy according to open, laparoscopic and robot-assisted surgical approach and clinicopathological stage. Material and methods.- A cohort study of 1313 consecutive patients treated by radical prostatectomy for localized or locally advanced prostate cancer between 2000 and 2013. Open surgery (63.7%), laparoscopy (10%) and robot-assisted laparoscopy (26.4%) were performed. Biochemical recurrence was defined by PSA > 0,1 ng/mL. The biochemical recurrence free survival was described by Kaplan Meier method and prognostic factors were analysed by multivariable Cox regression. Results. - Median follow-up was 57 months (IQR: 31-90). Ten years biochemical recurrence free survival was 88.5%, 71.6% and 53.5% respectively for low, intermediate and high-risk D'Amico groups. On multivariable analysis, the worse prognostic factor was Gleason score (P < 0.001). Positive surgical margins rate was 53% in pT3 tumours and 24% in pT2 tumours (P < 0.001). Biochemical recurrence free survival (P = 0.06) and positive surgical margins rate (P = 0.87) were not statistically different between the three surgical approaches. Conclusion. - Biochemical recurrence free survival in our study does not differ according to surgical approach and is similar to published series. Ten years biochemical recurrence free survival for high-risk tumours without hormone therapy is 54% justifying the role of surgery in the therapeutic conversations in this group of tumours. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:157 / 168
页数:12
相关论文
共 26 条
  • [1] Laparoscopic radical prostatectomy: Preliminary results
    Abbou, CC
    Salomon, L
    Hoznek, A
    Antiphon, P
    Cicco, A
    Saint, F
    Alame, W
    Bellot, J
    Chopin, DK
    [J]. UROLOGY, 2000, 55 (05) : 630 - 633
  • [2] Impact of Positive Surgical Margins After Radical Prostatectomy Differs by Disease Risk Group
    Alkhateeb, Sultan
    Alibhai, Shabbir
    Fleshner, Neil
    Finelli, Antonio
    Jewett, Michael
    Zlotta, Alexandre
    Nesbitt, Michael
    Lockwood, Gina
    Trachtenberg, John
    [J]. JOURNAL OF UROLOGY, 2010, 183 (01) : 145 - 150
  • [3] Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer
    Bill-Axelson, Anna
    Holmberg, Lars
    Garmo, Hans
    Rider, Jennifer R.
    Taari, Kimmo
    Busch, Christer
    Nordling, Stig
    Haggman, Michael
    Andersson, Swen-Olof
    Spangberg, Anders
    Andren, Ove
    Palmgren, Juni
    Steineck, Gunnar
    Adami, Hans-Olov
    Johansson, Jan-Erik
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (10) : 932 - 942
  • [4] Cancer incidence and mortality in France over the 1980-2012 period: Solid tumors
    Binder-Foucard, F. p
    Bossard, N.
    Delafosse, P.
    Belot, A.
    Woronoff, A. -S.
    Remontet, L.
    [J]. REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2014, 62 (02): : 95 - 108
  • [5] Mayo Clinic validation of the D'Amico risk group classification for predicting survival following radical prostatectomy
    Boorjian, Stephen A.
    Karnes, R. Jeffrey
    Rangel, Laureano J.
    Bergstralh, Eric J.
    Blute, Michael L.
    [J]. JOURNAL OF UROLOGY, 2008, 179 (04) : 1354 - 1360
  • [6] Functional Outcomes and Complications Following Radiation Therapy for Prostate Cancer: A Critical Analysis of the Literature
    Budaeus, Lars
    Bolla, Michel
    Bossi, Alberto
    Cozzarini, Cesare
    Crook, Juanita
    Widmark, Anders
    Wiegel, Thomas
    [J]. EUROPEAN UROLOGY, 2012, 61 (01) : 112 - 127
  • [7] Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer
    Carver, Brett S.
    Bianco, Fernando J., Jr.
    Scardino, Peter T.
    Eastham, James A.
    [J]. JOURNAL OF UROLOGY, 2006, 176 (02) : 564 - 568
  • [8] The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
    Epstein, JI
    Allsbrook, WC
    Amin, MB
    Egevad, LL
    Bastacky, S
    Beltrán, AL
    Berner, A
    Billis, A
    Boccon-Gibod, L
    Cheng, L
    Civantos, F
    Cohen, C
    Cohen, MB
    Datta, M
    Davis, C
    Delahunt, B
    Delprado, W
    Eble, JN
    Foster, CS
    Furusato, M
    Gaudin, PB
    Grignon, DJ
    Humphrey, PA
    Iczkowski, KA
    Jones, EC
    Lucia, S
    McCue, PA
    Nazeer, T
    Oliva, E
    Pan, CC
    Pizov, G
    Reuter, V
    Samaratunga, H
    Sebo, T
    Sesterhenn, I
    Shevchuk, M
    Srigley, JR
    Suzigan, S
    Takahashi, H
    Tamboli, P
    Tan, PH
    Têtu, B
    Tickoo, S
    Tomaszewski, JE
    Troncoso, P
    Tsuzuki, T
    True, LD
    van der Kwast, T
    Wheeler, TM
    Wojno, KJ
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (09) : 1228 - 1242
  • [9] Guillonneau B, 1999, PROSTATE, V39, P71
  • [10] Joniau S, 2014, EUR UROL